Morrell, Liz http://orcid.org/0000-0001-6382-1795
Buchanan, James
Rees, Sian
Barker, Richard W.
Wordsworth, Sarah
Funding for this research was provided by:
Cancer Research UK
Article History
Accepted: 13 July 2021
First Online: 19 August 2021
Declarations
:
: This work was funded by a grant from the Policy Department, Cancer Research UK. Open Access publication was funded by the Charities Open Access Fund.
: Liz Morrell, James Buchanan and Sarah Wordsworth declare no conflicts of interest. Richard W. Barker is founder and CEO of New Medicine Partners, co-founder of Metadvice and Innohealth, non-executive Director for the Image Analysis Group, Chair of the Health Innovation Network (UK), and was a non-executive director of Celgene Corporation. Sian Rees carried out research projects for Oxfordshire Clinical Commissioning Group (part of NHS England, UK) and Applied Research Collaboration South London (a health service research collaboration, UK).
: The dataset for this study is available from the corresponding author on reasonable request.
: Ethical approval was granted by the University of Oxford Medical Sciences Interdivisional Research Ethics Committee (R52559/RE003).
: All respondents provided informed consent before entering the study.
: LM and JB designed the study and identified attributes and levels, with input from SR and SW. JB created the experimental design, verified by LM. LM co-ordinated the fieldwork and performed the analysis, with some analysis code provided by JB. LM, JB and SW interpreted the results, with input from SR and RWB. RWB secured funding. LM drafted the manuscript, with critical review by all authors.